US 2022/0177582 A1 · NON-CONSENSUS GLYCOSYLATION OF BISPECIFIC ANTIBODIES

Abstract

The present invention relates to antibodies or antibody fragments comprising non-consensus glycosylation. The present invention also relates to methods to remove and measure said non-consensus glycosylation.

Claims8

Dependent claims

A purified antibody or fragment thereof comprising a single chain variable fragment which is glycosylated in at least one non-consensus glycosylation site.

Dependencies are inferred from the claim text.

Facts

Application

17/438,209Filed 13 Mar 2020

Priority

EP 19162632.413 Mar 2019

Published

9 Jun 2022

Term ends

Not estimatedThe source records don’t support an estimate.

Classification10 codes

C07K 16/2809
Against the immunoglobulin superfamily: against the T-cell receptor -CD3 complex
C07K 16/2863
Against receptors, cell surface antigens or cell surface determinants: against receptors for growth factors, growth regulators
C07K 16/2896
Against receptors, cell surface antigens or cell surface determinants: against molecules with a "CD"-designation, not provided for elsewhere
C07K 2317/14
Characterized by their source of isolation or production: specific host cells or culture conditions, e.g. components, pH or temperature

Non-consensus glycosylation of bispecific antibodies

Life of this patent

Abstract

Claims8

Non-consensus glycosylation of bispecific antibodies

Life of this patent

Abstract

Claims8